Back
  1. Home
  3. Detailled Reference
Request a copy
Paper published in a journal (Scientific congresses and symposiums)
Despite inhibitory effects on normal hematopoiesis in vitro, Imatinib and Nilotinib do not prevent engraftment of human CD34+ HSCs in immunodeficient NSG mice
Belle, Ludovic; Baron, Frédéric; Bruck, France et al.
2011 • In Belgian Journal of Hematology
Peer Reviewed verified by ORBi
Permalink
https://hdl.handle.net/2268/210612
 

Files (1)Send toDetailsStatisticsBibliographySimilar publications

Files

Full Text
Belle-P-BHS2011.pdf
Publisher postprint (27.38 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to


Details


Keywords :
GVHD; TKIs; Allo-HSCT
Disciplines :
Hematology
Author, co-author :
Belle, Ludovic ;  Université de Liège > GIGA-R : Hématologie
Baron, Frédéric  ;  Université de Liège > GIGA-R : Hématologie
Bruck, France
Hannon, Muriel ;  Université de Liège > GIGA-R : Hématologie
SERVAIS, Sophie ;  Centre Hospitalier Universitaire de Liège - CHU > Service d'hématologie clinique
Beguin, Yves  ;  Université de Liège > GIGA-R : Hématologie
BRIQUET, Alexandra ;  Centre Hospitalier Universitaire de Liège - CHU > Service d'hématologie clinique
Language :
English
Title :
Despite inhibitory effects on normal hematopoiesis in vitro, Imatinib and Nilotinib do not prevent engraftment of human CD34+ HSCs in immunodeficient NSG mice
Publication date :
January 2011
Event name :
26th General Annual Meeting of the Belgian Hematological Society
Event date :
Du 28 au 29 janvier 2011
Journal title :
Belgian Journal of Hematology
ISSN :
2033-3749
Publisher :
Ariez Medical Publishing, Amsterdam, Netherlands
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 17 May 2017

Statistics

Number of views
28 (1 by ULiège)
Number of downloads
0 (0 by ULiège)
More statistics

Bibliography

Similar publications


Contact ORBi